“Emerging PSA-based tests to improve screening”

Por Bryant, Richard J., Lilja, Hans G.
Publicado em 2014

Tissue microarray analysis indicates hedgehog signaling as a potential prognostic factor in intermediate-risk prostate cancer

Por Gonnissen, Annelies, Isebaert, Sofie, Perneel, Christiaan, McKee, Chad M., Verrill, Clare, Bryant, Richard J., Van Utterbeeck, Filip, Lerut, Evelyne, Haustermans, Karin, Muschel, Ruth J.
Publicado no BMC Cancer (2017)

Predicting High-Grade Cancer at Ten-Core Prostate Biopsy Using Four Kallikrein Markers Measured in Blood in the ProtecT Study

Por Bryant, Richard J., Sjoberg, Daniel D., Vickers, Andrew J., Robinson, Mary C., Kumar, Rajeev, Marsden, Luke, Davis, Michael, Scardino, Peter T., Donovan, Jenny, Neal, David E., Lilja, Hans, Hamdy, Freddie C.
Publicado no J Natl Cancer Inst (2015)

Altered expression of epithelial-to-mesenchymal transition proteins in extraprostatic prostate cancer

Por Verrill, Clare, Cerundolo, Lucia, Mckee, Chad, White, Michael, Kartsonaki, Christiana, Fryer, Eve, Morris, Emma, Brewster, Simon, Ratnayaka, Indrika, Marsden, Luke, Lilja, Hans, Muschel, Ruth, Lu, Xin, Hamdy, Freddie, Bryant, Richard J.
Publicado no Oncotarget (2015)

TOPK modulates tumour-specific radiosensitivity and correlates with recurrence after prostate radiotherapy

Por Pirovano, Giacomo, Ashton, Thomas M, Herbert, Katharine J, Bryant, Richard J, Verrill, Clare L, Cerundolo, Lucia, Buffa, Francesca M, Prevo, Remko, Harrap, Iona, Ryan, Anderson J, Macaulay, Valentine, McKenna, William G, Higgins, Geoff S
Publicado no Br J Cancer (2017)